Cancer associated fibroblasts in hematological malignancies

Lizzia Raffaghello; Angelo Vacca; Vito Pistoia; Domenico Ribatti

doi:10.18632/oncotarget.2661

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Reviews:

Cancer associated fibroblasts in hematological malignancies

Lizzia Raffaghello _, Angelo Vacca, Vito Pistoia and Domenico Ribatti

PDF | HTML | How to cite

Oncotarget. 2015; 6:2589-2603. https://doi.org/10.18632/oncotarget.2661

Metrics: PDF 3737 views | HTML 4983 views | ?

Abstract

Lizzia Raffaghello1, Angelo Vacca2, Vito Pistoia1, Domenico Ribatti3

1Laboratorio di Oncologia, Istituto G. Gaslini, Genova, Italy

2Department of Internal Medicine and Clinical Oncology, University of Bari Medical School, Bari, Italy

3Department of Basic Medical Sciences, Neurosciences and Sensory Organs, University of Bari Medical School, Bari, Italy, National Cancer Institute “Giovanni Paolo II”, Bari, Italy

Correspondence to:

Domenico Ribatti, e-mail: [email protected]

Keywords: cancer associated fibroblasts, mesenchymal stromal cells, hematological malignancies, tumor microenvironment

Received: September 03, 2014 Accepted: October 27, 2014 Published: December 06, 2014

ABSTRACT

Tumor microenvironment plays an important role in cancer initiation and progression. In hematological malignancies, the bone marrow represents the paradigmatic anatomical site in which tumor microenvironment expresses its morphofunctional features. Among the cells participating in the composition of this microenvironment, cancer associated fibrobasts (CAFs) have received less attention in hematopoietic tumors compared to solid cancers. In this review article, we discuss the involvement of CAFs in progression of hematological malignancies and the potential targeting of CAFs in a therapeutic perspective.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 2661

Publication Alerts

Post-Publication Promotion

Publication Discount

Reviews:

Cancer associated fibroblasts in hematological malignancies

Abstract